Os Therapies Incorporated
(OSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 03-2003 | 12-2002 | 09-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 172 | N/A | N/A | N/A |
| Other current assets | 0 | 326 | 200 | 170 | 200 |
| TOTAL | $0 | $497 | $200 | $170 | $200 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 120 | 80 | 700 |
| TOTAL | $N/A | $N/A | $120 | $80 | $700 |
| Total Assets | $0 | $509 | $320 | $250 | $900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 1,225 | 730 | 620 | 1,010 |
| Accrued Expenses | 0 | 1,665 | 570 | 650 | 550 |
| Other current liabilities | 0 | 3,258 | 130 | 180 | 110 |
| TOTAL | $0 | $6,148 | $3,890 | $3,300 | $2,380 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 11,919 | 0 | 0 | 0 |
| TOTAL | $N/A | $11,919 | $570 | $590 | $700 |
| Total Liabilities | $0 | $18,066 | $4,460 | $3,890 | $3,080 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 5 | 120 | 120 | 120 |
| Retained earnings | 0 | -21,602 | N/A | N/A | N/A |
| Other shareholders' equity | 0 | 2 | 0 | 0 | 1 |
| TOTAL | $0 | $-17,557 | $45,880 | $45,880 | $45,881 |
| Total Liabilities And Equity | $0 | $509 | $50,340 | $49,770 | $48,961 |